Possibility and probability favour them in war and peace: 10 large-cap stocks from 2 sectors with upside potential of up to 28%Probability theory is important in the stock market. Reason: Stock prices are a function of many factors and the underlying operating matri...
09 Mar, 2026, 05.58 AM IST
Being tactical not an option, but a necessity: Prescription for war and volatility; 7 pharma stocks with upside potential of up to 39%In times of major geopolitical conflicts, there is no point in looking at the day-to-day movement of the Nifty and Sensex. There are some s...
02 Mar, 2026, 12.31 PM IST
Pharma stocks: Time to change the prescription? 13 pharma stocks with an upside potential of up to 39%Close to three decades back, when Indian pharma firms began to move into the US market, they faced many challenges. And the fact is that th...
02 Jan, 2026, 12.39 PM IST
Indian or MNC pharma companies? There are reasons to look at both: 5 pharma stocks with upside potential of up to 38%Around two decades ago, as Indian pharma firms first began to move into the US market, they faced many challenges, the biggest of which was...
08 Dec, 2025, 03.52 PM IST
Healthcare stocks: Better to own a collection? 16 stocks from different segments with upside potential of 10 to 35% in 1 yearBefore you read on, be clear about one thing. The stocks on our list today are expensive in terms of valuations and may well witness correc...
30 Oct, 2025, 11.34 PM IST
These 5 pharma stocks can give more than 24% returns in one yearCheck out Stock Reports Plus, powered by Refinitiv, for price targets of over 4,000 listed stocks along with detailed company analysis focu...
29 Apr, 2024, 05.17 PM IST
JB Pharma open to more buys to grow branded biz shareJB Chemicals & Pharmaceuticals (JB Pharma), controlled by US private equity firm KKR, is evaluating assets for acquisitions to strengthen i...
24 Nov, 2023, 11.58 PM IST
Tailwinds at the right time: 7 pharma stocks with an upside potential up to 37 %It is not very common to see tailwinds emerging for an industry at a time when it is ideal to own stocks from that space. But in the case o...
07 Oct, 2023, 11.11 PM IST
Tactical buys in time of correction? 4 MNC pharma stocks with upside potential of up to 28%In the last two decades MNC pharma companies, whose parent companies were setting up 100 percent owned subsidiaries in India and started ro...
12 Sep, 2023, 02.36 PM IST
Will they make a comeback? 4 MNC pharma stocks with upside potential of up to 28%After the IT bull of 2000, as a new set of Indian companies took the centerstage, a number of MNCs stocks lost their shine at least on the ...
09 Sep, 2023, 02.44 PM IST
Nifty healthcare index stocks; Staying bullish on select pharma and hospitalsWhile they clubbed together, the operating matrix of a pharma company making drugs and hospital and a diagnostic company are very different...
01 Sep, 2023, 01.34 PM IST
Marksans Pharma gets final USFDA nod for generic version of Famotidine tabletsMarksans Pharma Ltd on Friday said it has received final approval from the US health regulator for its generic version of Famotidine tablet...
10 Mar, 2023, 01.34 PM IST
Dr Reddy’s recalled all batches of heartburn drug from USRanitidine is commonly prescribed as an antacid and the NDMA impurity scandal had rocked Indian generic makers present in US who were one o...
25 Oct, 2019, 08.52 AM IST
The colour purple that has left drug makers like Dr Reddy's Laboratories paleThe reference here has nothing to do with the Pulitzer-winning book of Alice Walker, but the actual colour that has pushed big pharma to pu...
14 Nov, 2015, 02.53 PM IST
US court imposes temporary sales ban on Dr Reddy’s generic antacidThe order has come on a suit filed by AstraZeneca, which objected to the Indian company using purple colour for the generic version.
11 Nov, 2015, 04.00 AM IST
- Strides Arcolab gets USFDA nod for anti-diabetic drug
Drug firm Strides Arcolab today said it has received the US health regulator's nod to market Acarbose tablets, an anti-diabetic drug, in th...
28 Jul, 2011, 03.20 PM IST
- Popular drugs a waste of money?
They are some of the most common drugs consumed in India. But PM’s high-level expert group on universal health coverage claims that they ar...
10 Mar, 2011, 08.54 AM IST